Predicting the efficiency of chidamide in patients with angioimmunoblastic T-cell lymphoma using machine learning algorithm

• Main Authors: Chunlan Zhang (Author), Juan Xu (Author), Mingyu Gu (Author), Yun Tang (Author), Wenjiao Tang (Author), Jie Wang (Author), Qinyu Liu (Author), Yunfan Yang (Author), Xushu Zhong (Author), Caigang Xu (Author)
• Format: Book
• Published: Frontiers Media S.A., 2024-08-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

BackgroundChidamide is subtype-selective histone deacetylase (HDAC) inhibitor that showed promising result in clinical trials to improve prognosis of angioimmunoblastic T-cell lymphoma (AITL) patients. However, in real world settings, contradictory reports existed as to whether chidamide improve ove...